SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001140361-23-046067
Filing Date
2023-09-29
Accepted
2023-09-29 17:24:40
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 ny20011553x1_s3.htm S-3 412303
2 EXHIBIT 5.1 ny20011553x1_ex5-1.htm EX-5.1 29024
3 EXHIBIT 5.2 ny20011553x1_ex5-2.htm EX-5.2 14934
4 EXHIBIT 23.1 ny20011553x1_ex23-1.htm EX-23.1 2140
5 FILING FEES TABLE ny20011553x1_ex107.htm EX-FILING FEES 38251
6 logo_conyers.jpg GRAPHIC 125236
7 logo_davispolk.jpg GRAPHIC 139041
8 logo_roivant02x1.jpg GRAPHIC 38331
  Complete submission text file 0001140361-23-046067.txt   914084
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE, 2 CHURCH STREET HAMILTON HM11 D0 HM11 441-295-5950
Roivant Sciences Ltd. (Filer) CIK: 0001635088 (see all company filings)

IRS No.: 981173944 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: S-3 | Act: 33 | File No.: 333-274804 | Film No.: 231296775
SIC: 2834 Pharmaceutical Preparations